BIO BIOTON S.A.
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diabetic drugs.BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.…
Industry Peers
BiotechnologyKey Statistics
About BIOTON (WSE: BIO)
›
BIOTON (WSE: BIO) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 3.415 PLN on 19 November 2026, down 18.9% over 52 weeks. Its 52-week range is 3.300 PLN to 4.510 PLN: the price is 24.3% below the high and 3.5% above the low.
Its market capitalisation is 293.23M PLN.
BIOTON reports return on equity of 0.6%, an operating margin of -1.3% and revenue down 10.7% year over year.
Its debt exceeds its cash by 78.78M PLN, a debt-to-equity ratio of 0.10. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health.